- call +1-201-465-4211
- email sales@mrinsights.biz
The synthetic version of progesterone, 17α-hydroxy-6α-methylprogesterone acetate is also known by the name Medroxyprogesterone Acetate. Medroxyprogesterone acetate is a more potent derivative of medroxyprogesterone and what is normally injected is its acetate derivative. Medroxyprogesterone acetate is administered every 3 months which in turn prevents ovulation and follicular maturation in endometrial thinning producing a contraceptive effect.
Scope of the Report:
This report focuses on the Medroxyprogesterone Acetate in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
The presence of major market players, technology advancements and research investments has made North America the dominating region for the cardiac biomarkers market. Moreover, there are many startups who are trying to enter the medroxyprogesterone acetate market with new technologies and more efficacy.
The worldwide market for Medroxyprogesterone Acetate is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Pfizer
Fangtong Pharma
Gador
Sigma-Aldrich
Teva Pharmaceutical
Greenstone
Serum Internation
West-Coast Pharmaceutical
Arrow Pharma Group
Zuche Pharmaceuticals
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Oral
Parenteral
Market Segment by Applications, can be divided into
Contraceptive
Hormone Replacement Therapy
Treatment of Endometriosis
Other
There are 15 Chapters to deeply display the global Medroxyprogesterone Acetate market.
Chapter 1, to describe Medroxyprogesterone Acetate Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Medroxyprogesterone Acetate, with sales, revenue, and price of Medroxyprogesterone Acetate, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Medroxyprogesterone Acetate, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Medroxyprogesterone Acetate market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Medroxyprogesterone Acetate sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Medroxyprogesterone Acetate Introduction
1.2 Market Analysis by Type
1.2.1 Oral
1.2.2 Parenteral
1.3 Market Analysis by Applications
1.3.1 Contraceptive
1.3.2 Hormone Replacement Therapy
1.3.3 Treatment of Endometriosis
1.3.4 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Business Overview
2.1.2 Medroxyprogesterone Acetate Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Pfizer Medroxyprogesterone Acetate Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Fangtong Pharma
2.2.1 Business Overview
2.2.2 Medroxyprogesterone Acetate Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Fangtong Pharma Medroxyprogesterone Acetate Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Gador
2.3.1 Business Overview
2.3.2 Medroxyprogesterone Acetate Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Gador Medroxyprogesterone Acetate Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Sigma-Aldrich
2.4.1 Business Overview
2.4.2 Medroxyprogesterone Acetate Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Sigma-Aldrich Medroxyprogesterone Acetate Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Teva Pharmaceutical
2.5.1 Business Overview
2.5.2 Medroxyprogesterone Acetate Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Teva Pharmaceutical Medroxyprogesterone Acetate Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Greenstone
2.6.1 Business Overview
2.6.2 Medroxyprogesterone Acetate Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Greenstone Medroxyprogesterone Acetate Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Serum Internation
2.7.1 Business Overview
2.7.2 Medroxyprogesterone Acetate Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Serum Internation Medroxyprogesterone Acetate Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 West-Coast Pharmaceutical
2.8.1 Business Overview
2.8.2 Medroxyprogesterone Acetate Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 West-Coast Pharmaceutical Medroxyprogesterone Acetate Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Arrow Pharma Group
2.9.1 Business Overview
2.9.2 Medroxyprogesterone Acetate Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Arrow Pharma Group Medroxyprogesterone Acetate Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Zuche Pharmaceuticals
2.10.1 Business Overview
2.10.2 Medroxyprogesterone Acetate Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Zuche Pharmaceuticals Medroxyprogesterone Acetate Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Medroxyprogesterone Acetate Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Medroxyprogesterone Acetate Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Medroxyprogesterone Acetate Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Medroxyprogesterone Acetate Manufacturer Market Share in 2017
3.3.2 Top 6 Medroxyprogesterone Acetate Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Medroxyprogesterone Acetate Market Analysis by Regions
4.1 Global Medroxyprogesterone Acetate Sales, Revenue and Market Share by Regions
4.1.1 Global Medroxyprogesterone Acetate Sales and Market Share by Regions (2013-2018)
4.1.2 Global Medroxyprogesterone Acetate Revenue and Market Share by Regions (2013-2018)
4.2 North America Medroxyprogesterone Acetate Sales and Growth Rate (2013-2018)
4.3 Europe Medroxyprogesterone Acetate Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Medroxyprogesterone Acetate Sales and Growth Rate (2013-2018)
4.5 South America Medroxyprogesterone Acetate Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Medroxyprogesterone Acetate Sales and Growth Rate (2013-2018)
5 North America Medroxyprogesterone Acetate by Countries
5.1 North America Medroxyprogesterone Acetate Sales, Revenue and Market Share by Countries
5.1.1 North America Medroxyprogesterone Acetate Sales and Market Share by Countries (2013-2018)
5.1.2 North America Medroxyprogesterone Acetate Revenue and Market Share by Countries (2013-2018)
5.2 United States Medroxyprogesterone Acetate Sales and Growth Rate (2013-2018)
5.3 Canada Medroxyprogesterone Acetate Sales and Growth Rate (2013-2018)
5.4 Mexico Medroxyprogesterone Acetate Sales and Growth Rate (2013-2018)
6 Europe Medroxyprogesterone Acetate by Countries
6.1 Europe Medroxyprogesterone Acetate Sales, Revenue and Market Share by Countries
6.1.1 Europe Medroxyprogesterone Acetate Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Medroxyprogesterone Acetate Revenue and Market Share by Countries (2013-2018)
6.2 Germany Medroxyprogesterone Acetate Sales and Growth Rate (2013-2018)
6.3 UK Medroxyprogesterone Acetate Sales and Growth Rate (2013-2018)
6.4 France Medroxyprogesterone Acetate Sales and Growth Rate (2013-2018)
6.5 Russia Medroxyprogesterone Acetate Sales and Growth Rate (2013-2018)
6.6 Italy Medroxyprogesterone Acetate Sales and Growth Rate (2013-2018)
7 Asia-Pacific Medroxyprogesterone Acetate by Countries
7.1 Asia-Pacific Medroxyprogesterone Acetate Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Medroxyprogesterone Acetate Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Medroxyprogesterone Acetate Revenue and Market Share by Countries (2013-2018)
7.2 China Medroxyprogesterone Acetate Sales and Growth Rate (2013-2018)
7.3 Japan Medroxyprogesterone Acetate Sales and Growth Rate (2013-2018)
7.4 Korea Medroxyprogesterone Acetate Sales and Growth Rate (2013-2018)
7.5 India Medroxyprogesterone Acetate Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Medroxyprogesterone Acetate Sales and Growth Rate (2013-2018)
8 South America Medroxyprogesterone Acetate by Countries
8.1 South America Medroxyprogesterone Acetate Sales, Revenue and Market Share by Countries
8.1.1 South America Medroxyprogesterone Acetate Sales and Market Share by Countries (2013-2018)
8.1.2 South America Medroxyprogesterone Acetate Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Medroxyprogesterone Acetate Sales and Growth Rate (2013-2018)
8.3 Argentina Medroxyprogesterone Acetate Sales and Growth Rate (2013-2018)
8.4 Colombia Medroxyprogesterone Acetate Sales and Growth Rate (2013-2018)
9 Middle East and Africa Medroxyprogesterone Acetate by Countries
9.1 Middle East and Africa Medroxyprogesterone Acetate Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Medroxyprogesterone Acetate Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Medroxyprogesterone Acetate Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Medroxyprogesterone Acetate Sales and Growth Rate (2013-2018)
9.3 UAE Medroxyprogesterone Acetate Sales and Growth Rate (2013-2018)
9.4 Egypt Medroxyprogesterone Acetate Sales and Growth Rate (2013-2018)
9.5 Nigeria Medroxyprogesterone Acetate Sales and Growth Rate (2013-2018)
9.6 South Africa Medroxyprogesterone Acetate Sales and Growth Rate (2013-2018)
10 Global Medroxyprogesterone Acetate Market Segment by Type
10.1 Global Medroxyprogesterone Acetate Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Medroxyprogesterone Acetate Sales and Market Share by Type (2013-2018)
10.1.2 Global Medroxyprogesterone Acetate Revenue and Market Share by Type (2013-2018)
10.2 Oral Sales Growth and Price
10.2.1 Global Oral Sales Growth (2013-2018)
10.2.2 Global Oral Price (2013-2018)
10.3 Parenteral Sales Growth and Price
10.3.1 Global Parenteral Sales Growth (2013-2018)
10.3.2 Global Parenteral Price (2013-2018)
11 Global Medroxyprogesterone Acetate Market Segment by Application
11.1 Global Medroxyprogesterone Acetate Sales Market Share by Application (2013-2018)
11.2 Contraceptive Sales Growth (2013-2018)
11.3 Hormone Replacement Therapy Sales Growth (2013-2018)
11.4 Treatment of Endometriosis Sales Growth (2013-2018)
11.5 Other Sales Growth (2013-2018)
12 Medroxyprogesterone Acetate Market Forecast (2018-2023)
12.1 Global Medroxyprogesterone Acetate Sales, Revenue and Growth Rate (2018-2023)
12.2 Medroxyprogesterone Acetate Market Forecast by Regions (2018-2023)
12.2.1 North America Medroxyprogesterone Acetate Market Forecast (2018-2023)
12.2.2 Europe Medroxyprogesterone Acetate Market Forecast (2018-2023)
12.2.3 Asia-Pacific Medroxyprogesterone Acetate Market Forecast (2018-2023)
12.2.4 South America Medroxyprogesterone Acetate Market Forecast (2018-2023)
12.2.5 Middle East and Africa Medroxyprogesterone Acetate Market Forecast (2018-2023)
12.3 Medroxyprogesterone Acetate Market Forecast by Type (2018-2023)
12.3.1 Global Medroxyprogesterone Acetate Sales Forecast by Type (2018-2023)
12.3.2 Global Medroxyprogesterone Acetate Market Share Forecast by Type (2018-2023)
12.4 Medroxyprogesterone Acetate Market Forecast by Application (2018-2023)
12.4.1 Global Medroxyprogesterone Acetate Sales Forecast by Application (2018-2023)
12.4.2 Global Medroxyprogesterone Acetate Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Medroxyprogesterone Acetate Picture
Table Product Specifications of Medroxyprogesterone Acetate
Figure Global Sales Market Share of Medroxyprogesterone Acetate by Ty
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
